Interaction Checker

Ofatumumab – now available on the interaction checker

Tuesday 20 March 2018

Ofatumumab is now listed in the interaction checker as a cancer drug and interactions can be found for all the comedications. 

Ofatumumab (Arzerra®) is a monoclonal antibody and is indicated for the treatment of chronic lymphocytic B-cell leukemia. 

ENDORSED BY
Bopa